0000950170-24-001849.txt : 20240104
0000950170-24-001849.hdr.sgml : 20240104
20240104160745
ACCESSION NUMBER: 0000950170-24-001849
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powl Brian T.
CENTRAL INDEX KEY: 0001934232
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 24511876
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
ownership.xml
4
X0508
4
2024-01-02
0001422143
Kura Oncology, Inc.
KURA
0001934232
Powl Brian T.
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO
CA
92130
false
true
false
false
Chief Commercial Officer
false
Common Stock
2024-01-02
4
A
false
15000
0
A
15000
D
Option to purchase common stock
15.36
2024-01-02
4
A
false
30000
0
A
2034-01-01
Common Stock
30000
30000
D
Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28.
This option vests in 48 equal monthly installments commencing on the grant date.
Teresa Bair, Attorney-in-fact for Brian Powl
2024-01-04